Dr. Nalini Murdter appointed CEO for MBLI by JSR Life Sciences

JSR life sciences of the JSR corporation confirmed the appointment of Dr. Nalini Murdter as the President and Chief Executive Officer of MBL International with effect immediately. Appointment followed by JSR’s acquisition of contract research organization, Crown Bio sciences.

Murdter asserted “I am excited to lead the organization into the next growth phase. Over the last year, MBLI has grown its business in the pharma and biotech industry and gained significant adoption of its products with leading researchers in the immuno-oncology field. Together with the greater JSR family of companies, I look forward to expanding our product and services business especially in immuno-oncology, autoimmune and metabolic disease areas.”

Experience encompasses from various fields like Murdter has served as Vice President of Commercial Operations and Business Development at MBLI, and Managing Director of the Diagnostics and Research Products Division at JSR. Dr. Murdter brings more than 25 years of experience in the life sciences and clinical diagnostics sectors. She was the Chief Business Officer at NanoString Technologies and held several senior management positions in business development, strategy and marketing at Agilent Technologies.